0.00Open0.00Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover116.34%IV-45.93%PremiumAug 16, 2024Expiry Date29.73Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9867Delta0.0018Gamma2.16Leverage Ratio-0.0181Theta0.0224Rho2.13Eff Leverage0.0057Vega
ANI Pharmaceuticals Stock Discussion
• $La-Z-Boy(LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US)$)
• $Ikena Oncology(IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $Repare Therapeutics(RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath(PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage(PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology(CRDO.US)$ +10.2% (In reaction ...
ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million Public Offering of Common Stock
https://www.businesswire.com/news/home/20211103006382/en/ANI-Pharmaceuticals-Inc.-Announces-Pricing-of-75-Million-Public-Offering-of-Common-Stock
wait for afternoon
currently nobody is selling and only buying. Let's hold to the moon.
No comment yet